Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Cogent Biosciences Inc (NASDAQ: COGT)

 
COGT Technical Analysis
4
As on 9th Jun 2023 COGT STOCK Price closed @ 12.01 and we RECOMMEND Buy for LONG-TERM with Stoploss of 9.77 & Strong Buy for SHORT-TERM with Stoploss of 7.34 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

COGTSTOCK Price

Open 11.48 Change Price %
High 12.07 1 Day 0.51 4.43
Low 11.25 1 Week 0.78 6.95
Close 12.01 1 Month 1.27 11.82
Volume 989882 1 Year 3.74 45.22
52 Week High 16.99 | 52 Week Low 3.92
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
COGT
Daily Charts		 COGT
Intraday Charts		 Whats New @
Bazaartrend		 COGT
Free Analysis
 
COGT Important Levels Intraday
RESISTANCE13.59
RESISTANCE13.08
RESISTANCE12.77
RESISTANCE12.46
SUPPORT11.56
SUPPORT11.25
SUPPORT10.94
SUPPORT10.43
 
COGT Forecast May 2024
Share
4th UP Forecast16.42
3rd UP Forecast15.01
2nd UP Forecast14.13
1st UP Forecast13.26
1st DOWN Forecast10.76
2nd DOWN Forecast9.89
3rd DOWN Forecast9.01
4th DOWN Forecast7.6
 
COGT Weekly Forecast
4th UP Forecast13.94
3rd UP Forecast13.32
2nd UP Forecast12.94
1st UP Forecast12.56
1st DOWN Forecast11.47
2nd DOWN Forecast11.08
3rd DOWN Forecast10.70
4th DOWN Forecast10.08
 
COGT Forecast2024
4th UP Forecast39.53
3rd UP Forecast30.7
2nd UP Forecast25.25
1st UP Forecast19.79
1st DOWN Forecast4.23
2nd DOWN Forecast-1.23
3rd DOWN Forecast-6.68
4th DOWN Forecast-15.51
 
 
COGT Other Details
Segment EQ
Market Capital 337120864.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
COGT Address
COGT
 
COGT Latest News
 
Your Comments and Response on Cogent Biosciences Inc
 
COGT Business Profile
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies to treat genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. Cogent Biosciences, Inc. has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of CGT9486 and CGT0206 inhibitors. The company was formerly known as Unum Therapeutics Inc. and changed its name to Cogent Biosciences, Inc. in October 2020. Cogent Biosciences, Inc. was founded in 2014 and is headquartered in Cambridge, Massachusetts. Address: 200 Cambridge Park Drive, Cambridge, MA, United States, 02140
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service